AR, androgen receptor, 367

N. diseases: 854; N. variants: 163
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
androgen independent prostate cancer
0.100 Biomarker disease BEFREE NO may play a role in the development of androgen-independent prostate cancer via s-nitrosylation of the androgen receptor. 28326819 2017
androgen independent prostate cancer
0.100 GeneticVariation disease BEFREE The T887A mutated AR was frequently expressed in androgen independent prostate cancer (AIPC) patients. 28757136 2017
androgen independent prostate cancer
0.100 AlteredExpression disease BEFREE The protein levels of Pim-1 and AR in the ADPC and AIPC groups were significantly different compared with the ADT group (P<0.01). 28599438 2017
androgen independent prostate cancer
0.100 Biomarker disease BEFREE Molecular cloning of canine co-chaperone small glutamine-rich tetratricopeptide repeat-containing protein α (SGTA) and investigation of its ability to suppress androgen receptor signalling in androgen-independent prostate cancer. 26346258 2015
androgen independent prostate cancer
0.100 Biomarker disease BEFREE Nanobubbles carrying AR siRNA could be potentially used as gene vectors in combination with ultrasonic irradiation for the treatment of AIPC. 24798477 2014
androgen independent prostate cancer
0.100 Biomarker disease BEFREE Identification of an anabolic selective androgen receptor modulator that actively induces death of androgen-independent prostate cancer cells. 24565564 2014
androgen independent prostate cancer
0.100 AlteredExpression disease BEFREE In the present study, we showed that the AR gene was upregulated by paired box 2 (PAX2) in androgen-independent prostate cancer. 25132193 2014
androgen independent prostate cancer
0.100 Biomarker disease BEFREE Our data suggest that AR primes androgen-independent prostate cancer cells to DNA damage-induced apoptosis through the PIRH2-p53-p21 axis. 23159636 2013
androgen independent prostate cancer
0.100 PosttranslationalModification disease BEFREE Effect of histone deacetylase and DNA methyltransferase inhibitors on the expression of the androgen receptor gene in androgen-independent prostate cancer cell lines. 23503510 2013
androgen independent prostate cancer
0.100 Biomarker disease BEFREE Several studies indicate that NcoA4 localizes predominantly to the cytoplasm and affects ligand-binding specificity of the androgen receptor, which has important implications for androgen-independent prostate cancer. 22562579 2012
androgen independent prostate cancer
0.100 AlteredExpression disease BEFREE Physalins A and B inhibit androgen-independent prostate cancer cell growth through activation of cell apoptosis and downregulation of androgen receptor expression. 21963499 2011
androgen independent prostate cancer
0.100 GeneticVariation disease BEFREE Results suggest that 17α-estradiol with less classic estrogenic activity is a potential therapeutic agent for androgen independent prostate cancer due to androgen receptor mutation. 21075385 2011
androgen independent prostate cancer
0.100 AlteredExpression disease BEFREE To determine whether PPARγ ligands are equally effective at inhibiting AR activity in androgen-independent prostate cancer, we examined the effect of the PPARγ ligands ciglitazone and rosiglitazone on C4-2 cells, an androgen- independent derivative of the LNCaP cell line. 20932825 2010
androgen independent prostate cancer
0.100 Biomarker disease BEFREE Anti-tumor effect of small interfering RNA targeting the androgen receptor in human androgen-independent prostate cancer cells. 20004643 2010
androgen independent prostate cancer
0.100 AlteredExpression disease BEFREE Recently, tyrosine kinase Ack1 has been shown to regulate AR activity by phosphorylating it at tyrosine 267 and this event was shown to be critical for AIPC growth. 20623637 2010
androgen independent prostate cancer
0.100 Biomarker disease BEFREE In summary, SNARE-1 inhibits AR function by a mechanism that is distinct from clinically available antiandrogens, such that it might inform novel methods to block AR function in androgen-independent prostate cancer. 20068182 2010
androgen independent prostate cancer
0.100 Biomarker disease BEFREE Molecular biology of androgen-independent prostate cancer: the role of the androgen receptor pathway. 19155198 2009
androgen independent prostate cancer
0.100 AlteredExpression disease BEFREE In this study, we examined LEF1 expression in androgen-independent cancer as well as its regulation of androgen receptor (AR) expression, prostate cancer growth, and invasion in androgen-independent prostate cancer cells. 19351848 2009
androgen independent prostate cancer
0.100 AlteredExpression disease BEFREE Androgen receptor regulates a distinct transcription program in androgen-independent prostate cancer. 19632176 2009
androgen independent prostate cancer
0.100 AlteredExpression disease BEFREE Together, these data support the notion that ET-1, via Src/PI-3K signaling, augments c-myc expression leading to enhanced AR expression in PC. 18623111 2009
androgen independent prostate cancer
0.100 AlteredExpression disease BEFREE Five of those are dependent on the androgen receptor, which is present or over-expressed in androgen-independent prostate cancer tissue. 18262723 2008
androgen independent prostate cancer
0.100 Biomarker disease BEFREE These results demonstrate that the AR status determines the sensitivity of prostate cancer cells to the apoptotic effects of TGF-beta1, thus providing a new insight into the mechanism via which TGF-beta cross-sections the AR axis toward the functional convergence of the two pathways in the development of androgen-independent prostate cancer. 18163430 2008
androgen independent prostate cancer
0.100 AlteredExpression disease BEFREE Overexpression of the androgen receptor (AR) occurs in androgen-independent prostate cancer and has been proposed as another mechanism promoting the development of androgen independence. 18479901 2008
androgen independent prostate cancer
0.100 Biomarker disease BEFREE 5alpha-androstane-3alpha,17beta-diol supports human prostate cancer cell survival and proliferation through androgen receptor-independent signaling pathways: implication of androgen-independent prostate cancer progression. 18320593 2008
androgen independent prostate cancer
0.100 Biomarker disease BEFREE These data suggest that intracellular control of AR expression levels through the natural AR promoter might be needed for determining AR function in androgen-independent prostate cancer (AIPC) PC-3 cells. 17334587 2007